Center of Excellence of the European Union
 
Set page width to 800
Login
 
Selected publications

Articles

1.   Pomozi V, Le Saux O, Brampton CN, Apana AL, Iliás A, Martin L, Szeri F, Monostory K, Paku S, Sarkadi B, Szakács G and Varadi A (2013) [23625951]
  ABCC6 is a Basolateral Plasma Membrane Protein.
  Circ Res notSet,
2.   Telbisz Á, Özvegy-Laczka C, Hegedűs T, Váradi A and Sarkadi B (2013) [23205634]
  Effects of the lipid environment, cholesterol and bile acids on the function of the purified and reconstituted human ABCG2 protein.
  Biochem J 450, 387-95
3.   Uitto J, Váradi A, Bercovitch L, Terry PF and Terry SF (2013) [23673496]
  Pseudoxanthoma Elasticum: Progress in Research Toward Treatment: Summary of the 2012 PXE International Research Meeting.
  J Invest Dermatol 133, 1444-1449
4.   Arányi T, Bacquet C, de Boussac H, Ratajewski M, Pomozi V, Fülöp K, Brampton CN, Pulaski L, Saux OL and Váradi A (2013) [23483032]
  Transcriptional regulation of the ABCC6 gene and the background of impaired function of missense disease-causing mutations.
  Front Genet 4, 27
5.   Ratajewski M, de Boussac H, Sachrajda I, Bacquet C, Kovács T, Váradi A, Pulaski L and Arányi T (2012) [22763786]
  ABCC6 expression is regulated by CCAAT/enhancer-binding protein activating a primate-specific sequence located in the first intron of the gene.
  J Invest Dermatol 132, 2709-17
6.   Telbisz A, Hegedüs C, Ozvegy-Laczka C, Goda K, Várady G, Takáts Z, Szabó E, Sorrentino BP, Váradi A and Sarkadi B (2012) [22115866]
  Antibody binding shift assay for rapid screening of drug interactions with the human ABCG2 multidrug transporter.
  Eur J Pharm Sci 45, 101-9
7.   Hegedüs C, Truta-Feles K, Antalffy G, Várady G, Német K, Ozvegy-Laczka C, Kéri G, Orfi L, Szakács G, Settleman J, Váradi A and Sarkadi B (2012) [22548830]
  Interaction of the EGFR inhibitors gefitinib, vandetanib, pelitinib and neratinib with the ABCG2 multidrug transporter: implications for the emergence and reversal of cancer drug resistance.
  Biochem Pharmacol 84, 260-7
8.   Hegedüs C, Truta-Feles K, Antalffy G, Brózik A, Kasza I, Német K, Orbán TI, Özvegy-Laczka C, Váradi A and Sarkadi B (2012) [22449574]
  PI3-kinase and mTOR inhibitors differently modulate the function of the ABCG2 multidrug transporter.
  Biochem Bioph Res Co 420, 869-74
9.   de Boussac H, Orbán TI, Várady G, Tihanyi B, Bacquet C, Brózik A, Váradi A, Sarkadi B and Arányi T (2012) [22922104]
  Stimulus-induced expression of the ABCG2 multidrug transporter in HepG2 hepatocarcinoma model cells involves the ERK1/2 cascade and alternative promoters.
  Biochem Bioph Res Co 426, 172-6
10.   Le Saux O, Martin L, Aherrahrou Z, Leftheriotis G, Váradi A and Brampton CN (2012) [23248644]
  The molecular and physiological roles of ABCC6: more than meets the eye.
  Front Genet 3, 289
11.   Váradi A, Szabó Z, Pomozi V, de Boussac H, Fülöp K and Arányi T (2011) [21039331]
  ABCC6 as a target in pseudoxanthoma elasticum.
  Curr Drug Targets 12, 671-82
12.   Szabó Z, Váradi A, Li Q and Uitto J (2011) [21813308]
  ABCC6 does not transport adenosine - relevance to pathomechanism of pseudoxanthoma elasticum.
  Mol Genet Metab 104, 421; author reply 42
13.   Fülöp K, Jiang Q, Wetering KV, Pomozi V, Szabó PT, Arányi T, Sarkadi B, Borst P, Uitto J and Váradi A (2011) [22056557]
  ABCC6 does not transport vitamin K3-glutathione conjugate from the liver: relevance to pathomechanisms of pseudoxanthoma elasticum.
  Biochem Bioph Res Co 415, 468-71
14.   Le Saux O, Fülöp K, Yamaguchi Y, Iliás A, Szabó Z, Brampton CN, Pomozi V, Huszár K, Arányi T and Váradi A (2011) [21935449]
  Expression and In Vivo Rescue of Human ABCC6 Disease-Causing Mutants in Mouse Liver.
  PLoS ONE 6, e24738
15.   Arányi T, Fülöp K, Symmons O, Pomozi V and Váradi A (2011) [21082744]
  Predictable difficulty or difficulty to predict.
  Protein Sci 20, 1-3; author reply 4-
16.   Brampton C, Yamaguchi Y, Vanakker O, Van Laer L, Chen LH, Thakore M, De Paepe A, Pomozi V, Szabó PT, Martin L, Váradi A and Le Saux O (2011) [21597330]
  Vitamin K does not prevent soft tissue mineralization in a mouse model of pseudoxanthoma elasticum.
  Cell Cycle 10,
17.   Li Q, Sadowski S, Frank M, Chai C, Váradi A, Ho SY, Lou H, Dean M, Thisse C, Thisse B and Uitto J (2010) [20596085]
  The abcc6a gene expression is required for normal zebrafish development.
  J Invest Dermatol 130, 2561-8
18.   de Boussac H, Ratajewski M, Sachrajda I, Köblös G, Tordai A, Pulaski L, Buday L, Váradi A and Arányi T (2010) [20463007]
  The ERK1/2-hepatocyte nuclear factor 4alpha axis regulates human ABCC6 gene expression in hepatocytes.
  J Biol Chem 285, 22800-8
19.   Köblös G, Andrikovics H, Prohászka Z, Tordai A, Váradi A and Arányi T (2010) [19929409]
  The R1141X loss-of-function mutation of the ABCC6 gene is a strong genetic risk factor for coronary artery disease.
  Genet Test Mol Biomarkers 14, 75-8
20.   Fülöp K, Barna L, Symmons O, Závodszky P and Váradi A (2009) [19133228]
  Clustering of disease-causing mutations on the domain-domain interfaces of ABCC6.
  Biochem Bioph Res Co 379, 706-9
21.   Hegedűs C, Ozvegy-Laczka C, Apáti A, Magócsi M, Német K, Orfi L, Kéri G, Katona M, Takáts Z, Váradi A, Szakács G and Sarkadi B (2009) [19785662]
  Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties.
  Brit J Pharmacol 158, 1153-64
22.   Kasza I, Hegyi Z, Szabo K, Andrikovics H, Nemet K, Varadi A, Sarkadi B and Homolya L (2009) [20025763]
  Model system for the analysis of cell surface expression of human ABCA1.
  BMC Cell Biol 10, 93
23.   Li Q, Jiang Q, Pfendner E, Váradi A and Uitto J (2009) [19054062]
  Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanisms.
  Exp Dermatol 18, 1-11
24.   Szeri F, Iliás A, Pomozi V, Robinow S, Bakos E and Váradi A (2009) [19059376]
  The high turnover Drosophila multidrug resistance-associated protein shares the biochemical features of its human orthologues.
  Bba-biomembranes 1788, 402-9
25.   Bors A, Ribiczey P, Köblös G, Brózik A, Ujfaludi Z, Magócsi M, Váradi A, Tordai A, Kovács T and Arányi T (2008) [17945177]
  External cell control polymerase chain reaction: replacing internal standards with an unbiased strategy for quantitative polymerase chain reaction normalization.
  Anal Biochem 372, 261-3
26.   Symmons O, Váradi A and Arányi T (2008) [18791038]
  How segmental duplications shape our genome: recent evolution of ABCC6 and PKD1 Mendelian disease genes.
  Mol Biol Evol 25, 2601-13
27.   Özvegy-Laczka C, Laczkó R, Hegedűs C, Litman T, Várady G, Goda K, Hegedűs T, Dokholyan NV, Sorrentino BP, Váradi A and Sarkadi B (2008) [18644784]
  Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.
  J Biol Chem 283, 26059-70
28.   Szakács G, Váradi A, Ozvegy-Laczka C and Sarkadi B (2008) [18468555]
  The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME-Tox).
  Drug Discov Today 13, 379-393
29.   Telbisz A, Müller M, Ozvegy-Laczka C, Homolya L, Szente L, Váradi A and Sarkadi B (2007) [17662239]
  Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter.
  Bba-biomembranes 1768, 2698-713
30.   Müller M, Klein I, Kopácsi S, Remaley AT, Rajnavölgyi E, Sarkadi B and Váradi A (2006) [17055487]
  Co-expression of human ABCG5 and ABCG8 in insect cells generates an androstan stimulated membrane ATPase activity.
  FEBS Lett 580, 6139-44
31.   Patocs A, Klein I, Szilvasi A, Gergics P, Toth M, Valkusz Z, Forizs E, Igaz P, Al-Farhat Y, Tordai A, Varadi A, Racz K and Esik O (2006) [16865647]
  Genotype-phenotype correlations in Hungarian patients with hereditary medullary thyroid cancer.
  Wien Klin Wochenschr 118, 417-21
32.   Sarkadi B, Homolya L, Szakács G and Váradi A (2006) [17015488]
  Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system.
  Physiol Rev 86, 1179-236
33.   Tusnády GE, Sarkadi B, Simon I and Váradi A (2006) [16337630]
  Membrane topology of human ABC proteins.
  FEBS Lett 580, 1017-22
34.   Arányi T, Váradi A, Simon I and Tusnády GE (2006) [17022803]
  The BiSearch web server.
  BMC Bioinformatics 7, 431
35.   Cervenak J, Andrikovics H, Ozvegy-Laczka C, Tordai A, Német K, Váradi A and Sarkadi B (2006) [16337740]
  The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.
  Cancer Lett 234, 62-72
36.   Tusnády GE, Simon I, Váradi A and Arányi T (2005) [15653630]
  BiSearch: primer-design and search tool for PCR on bisulfite-treated genomes.
  Nucleic Acids Res 33, e9
37.   Ozvegy-Laczka C, Várady G, Köblös G, Ujhelly O, Cervenak J, Schuetz JD, Sorrentino BP, Koomen GJ, Váradi A, Német K and Sarkadi B (2005) [15557326]
  Function-dependent conformational changes of the ABCG2 multidrug transporter modify its interaction with a monoclonal antibody on the cell surface.
  J Biol Chem 280, 4219-27
38.   Cortés-Selva F, Muñoz-Martínez F, Iliás A, Jiménez AI, Váradi A, Gamarro F and Castanys S (2005) [15737615]
  Functional expression of a multidrug P-glycoprotein transporter of Leishmania.
  Biochem Bioph Res Co 329, 502-7
39.   Arányi T, Ratajewski M, Bardóczy V, Pulaski L, Bors A, Tordai A and Váradi A (2005) [15760889]
  Identification of a DNA methylation-dependent activator sequence in the pseudoxanthoma elasticum gene, ABCC6.
  J Biol Chem 280, 18643-50
40.   Elkind NB, Szentpétery Z, Apáti A, Ozvegy-Laczka C, Várady G, Ujhelly O, Szabó K, Homolya L, Váradi A, Buday L, Kéri G, Német K and Sarkadi B (2005) [15753373]
  Multidrug transporter ABCG2 prevents tumor cell death induced by the epidermal growth factor receptor inhibitor Iressa (ZD1839, Gefitinib).
  Cancer Res 65, 1770-7
41.   Ozvegy-Laczka C, Köblös G, Sarkadi B and Váradi A (2005) [15670731]
  Single amino acid (482) variants of the ABCG2 multidrug transporter: major differences in transport capacity and substrate recognition.
  Bba-biomembranes 1668, 53-63
42.   Sarkadi B, Ozvegy-Laczka C, Német K and Váradi A (2004) [15165903]
  ABCG2 -- a transporter for all seasons.
  FEBS Lett 567, 116-20
43.   Cserepes J, Szentpétery Z, Seres L, Ozvegy-Laczka C, Langmann T, Schmitz G, Glavinas H, Klein I, Homolya L, Váradi A, Sarkadi B and Elkind NB (2004) [15240127]
  Functional expression and characterization of the human ABCG1 and ABCG4 proteins: indications for heterodimerization.
  Biochem Bioph Res Co 320, 860-7
44.   Szentpétery Z, Sarkadi B, Bakos E and Váradi A (2004) [15152943]
  Functional studies on the MRP1 multidrug transporter: characterization of ABC-signature mutant variants.
  Anticancer Res 24, 449-55
45.   Kern A, Szentpétery Z, Liliom K, Bakos E, Sarkadi B and Váradi A (2004) [14759224]
  Nucleotides and transported substrates modulate different steps of the ATPase catalytic cycle of MRP1 multidrug transporter.
  Biochem J 380, 549-60
46.   Tarnay JN, Szeri F, Iliás A, Annilo T, Sung C, Le Saux O, Váradi A, Dean M, Boyd CD and Robinow S (2004) [15373810]
  The dMRP/CG6214 gene of Drosophila is evolutionarily and functionally related to the human multidrug resistance-associated protein family.
  Insect Mol Biol 13, 539-48
47.   Szentpétery Z, Kern A, Liliom K, Sarkadi B, Váradi A and Bakos E (2004) [15252017]
  The role of the conserved glycines of ATP-binding cassette signature motifs of MRP1 in the communication between the substrate-binding site and the catalytic centers.
  J Biol Chem 279, 41670-8
48.   Andrikovics H, Klein I, Bors A, Nemes L, Marosi A, Váradi A and Tordai A (2003) [12857556]
  Analysis of large structural changes of the factor VIII gene, involving intron 1 and 22, in severe hemophilia A.
  Haematol-hematol J 88, 778-84
49.   Ujhelly O, Ozvegy C, Várady G, Cervenak J, Homolya L, Grez M, Scheffer G, Roos D, Bates SE, Váradi A, Sarkadi B and Német K (2003) [12659681]
  Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells.
  Hum Gene Ther 14, 403-12
50.   Hegedüs T, Sessler T, Scott R, Thelin W, Bakos E, Váradi A, Szabó K, Homolya L, Milgram SL and Sarkadi B (2003) [12615054]
  C-terminal phosphorylation of MRP2 modulates its interaction with PDZ proteins.
  Biochem Bioph Res Co 302, 454-61
51.   Bodó A, Bakos É, Szeri F, Váradi A and Sarkadi B (2003) [12704183]
  Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions.
  J Biol Chem 278, 23529-37
52.   Homolya L, Váradi A and Sarkadi B (2003) [12897433]
  Multidrug resistance-associated proteins: Export pumps for conjugates with glutathione, glucuronate or sulfate.
  Biofactors 17, 103-14
53.   Sinkó E, Iliás A, Ujhelly O, Homolya L, Scheffer GL, Bergen AA, Sarkadi B and Váradi A (2003) [12901863]
  Subcellular localization and N-glycosylation of human ABCC6, expressed in MDCKII cells.
  Biochem Bioph Res Co 308, 263-9
54.   Bodó A, Bakos E, Szeri F, Váradi A and Sarkadi B (2003) [12676459]
  The role of multidrug transporters in drug availability, metabolism and toxicity.
  Toxicol Lett 140-141, 133-43
55.   Ozvegy C, Váradi A and Sarkadi B (2002) [12374800]
  Characterization of drug transport, ATP hydrolysis, and nucleotide trapping by the human ABCG2 multidrug transporter. Modulation of substrate specificity by a point mutation.
  J Biol Chem 277, 47980-90
56.   Hegedus T, Orfi L, Seprodi A, Váradi A, Sarkadi B and Kéri G (2002) [12084474]
  Interaction of tyrosine kinase inhibitors with the human multidrug transporter proteins, MDR1 and MRP1.
  Bba-mol Basis Dis 1587, 318-25
57.   Iliás A, Urbán Z, Seidl TL, Le Saux O, Sinkó E, Boyd CD, Sarkadi B and Váradi A (2002) [11880368]
  Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6).
  J Biol Chem 277, 16860-7
58.   Igaz P, Patócs A, Rácz K, Klein I, Váradi A and Esik O (2002) [12050290]
  Occurrence of pheochromocytoma in a MEN2A family with codon 609 mutation of the RET proto-oncogene.
  J Clin Endocr Metab 87, 2994
59.   Váradi A, Szakács G, Bakos E and Sarkadi B (2002) [11990782]
  P glycoprotein and the mechanism of multidrug resistance.
  Novartis Found Symp 243, 54-65; discussion 65
60.   Klein I, Andrikovics H, Bors A, Nemes L, Tordai A and Váradi A (2001) [11380636]
  A haemophilia A and B molecular genetic diagnostic programme in Hungary: a highly informative and cost-effective strategy.
  Haemophilia 7, 306-12
61.   Szakács G, Langmann T, Ozvegy C, Orsó E, Schmitz G, Váradi A and Sarkadi B (2001) [11700048]
  Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter.
  Biochem Bioph Res Co 288, 1258-64
62.   Ozvegy C, Litman T, Szakács G, Nagy Z, Bates S, Váradi A and Sarkadi B (2001) [11437380]
  Functional characterization of the human multidrug transporter, ABCG2, expressed in insect cells.
  Biochem Bioph Res Co 285, 111-7
63.   Klein I, Esik O, Homolya V, Szeri F and Váradi A (2001) [11524247]
  Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.
  J Endocrinol 170, 661-6
64.   Szakács G, Özvegy C, Bakos É, Sarkadi B and Váradi A (2001) [11336637]
  Role of glycine-534 and glycine-1179 of human multidrug resistance protein (MDR1) in drug-mediated control of ATP hydrolysis.
  Biochem J 356, 71-5
65.   Bakos É, Evers R, Calenda G, Tusnády GE, Szakács G, Váradi A and Sarkadi B (2000) [11082039]
  Characterization of the amino-terminal regions in the human multidrug resistance protein (MRP1).
  J Cell Sci 113 (Pt 2), 4451-61
66.   Kern A, Felföldi F, Sarkadi B and Váradi A (2000) [10891347]
  Expression and characterization of the N- and C-terminal ATP-binding domains of MRP1.
  Biochem Bioph Res Co 273, 913-9
67.   Bakos É, Evers R, Sinkó E, Váradi A, Borst P and Sarkadi B (2000) [10727523]
  Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions.
  Mol Pharmacol 57, 760-8
68.   Smith AJ, van Helvoort A, van Meer G, Szabó K, Welker E, Szakács G, Varadi A, Sarkadi B and Borst P (2000) [10918072]
  MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
  J Biol Chem 275, 23530-9
69.   Szakács G, Özvegy C, Bakos É, Sarkadi B and Váradi A (2000) [11027628]
  Transition-state formation in ATPase-negative mutants of human MDR1 protein.
  Biochem Bioph Res Co 276, 1314-9
70.   Welker E and Váradi A (2000) [10799330]
  Vectors with hidden cloning sites.
  Biochem Bioph Res Co 271, 534-6
71.   Klein I, Sarkadi B and Váradi A (1999) [10581359]
  An inventory of the human ABC proteins.
  Bba-biomembranes 1461, 237-62
72.   Sharom FJ, Yu X, Lu P, Liu R, Chu JW, Szabó K, Müller M, Hose CD, Monks A, Váradi A, Seprôdi J and Sarkadi B (1999) [10413294]
  Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.
  Biochem Pharmacol 58, 571-86
73.   Andrikovics H, Klein I, Kalmár L, Bors A, Jermendy G, Petri I, Kalász L, Váradi A and Tordai A (1999) [10586619]
  [A new method of molecular testing in the differential diagnosis of hereditary hemochromatosis]
  Orv Hetil 140, 2517-22
74.   Klein I, Homolya V, Váradi A and Esik O (1999) [10628190]
  [Molecular genetic study of medullary thyroid cancer]
  Orv Hetil 140, 2739-46
75.   Szabó K, Welker E, Bakos É, Müller M, Roninson I, Váradi A and Sarkadi B (1998) [9553060]
  Drug-stimulated nucleotide trapping in the human multidrug transporter MDR1. Cooperation of the nucleotide binding domains.
  J Biol Chem 273, 10132-8
76.   Bakos É, Evers R, Szakács G, Tusnády GE, Welker E, Szabó K, de Haas M, van Deemter L, Borst P, Váradi A and Sarkadi B (1998) [9822694]
  Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain.
  J Biol Chem 273, 32167-75
77.   Klein I and Varadi A (1998) [-100002664]
  Géntudósok.
  Természet Világa 129, 230-231
78.   Tordai A, Andrikovics H, Kalmár L, Rajczy K, Pénzes M, Sarkadi B, Klein I and Váradi A (1998) [9783719]
  High frequency of the haemochromatosis C282Y mutation in Hungary could argue against a Celtic origin of the mutation.
  J Med Genet 35, 878-9
79.   Váradi A, Tusnády GE, Bakos É and Sarkadi B (1998) [19002784]
  Membrane topology of human MRP homologs
  Cytotechnology 27, 71-79
80.   Tusnády GE and Váradi A (1998) [9464238]
  Short MRP may not be short.
  Biochem Bioph Res Co 242, 465-6
81.   Klein I, Tordai A, Nemes L, Sas G and Váradi A (1998) [9528291]
  [Indirect methods in the genetic diagnosis of hemophilia A]
  Orv Hetil 139, 487-91
82.   Falus A, Váradi A and Raskó I (1998) [9595930]
  [The DNA-chip, a new tool for medical genetics]
  Orv Hetil 139, 957-60
83.   Bakos É, Klein I, Welker E, Szabó K, Müller M, Sarkadi B and Váradi A (1997) [9169612]
  Characterization of the human multidrug resistance protein containing mutations in the ATP-binding cassette signature region.
  Biochem J 323 (Pt 3), 777-83
84.   Falus A, Varadi A and Rasko I (1997) [-100002660]
  DNS chipek: a molekuláris genetika új korszaka.
  Természet Világa 11, 491
85.   Tusnády GE, Bakos É, Váradi A and Sarkadi B (1997) [9013845]
  Membrane topology distinguishes a subfamily of the ATP-binding cassette (ABC) transporters.
  FEBS Lett 402, 1-3
86.   Szabó K, Bakos É, Welker E, Müller M, Goodfellow HR, Higgins CF, Váradi A and Sarkadi B (1997) [9287320]
  Phosphorylation site mutations in the human multidrug transporter modulate its drug-stimulated ATPase activity.
  J Biol Chem 272, 23165-71
87.   Tordai A, Klein I, Rajczy K, Pénzes M, Sarkadi B and Váradi A (1997) [9375776]
  Prevalence of factor V Leiden (Arg506Gln) in Hungary.
  Brit J Haematol 99, 466-7
88.   Ferenczi A, Homolya V, Szakács G, Németh K, Kiss E, Váradi A and Fekete G (1997) [9072754]
  [Clinical application of analysis of microsatellite markers in the prenatal diagnosis of cystic fibrosis]
  Orv Hetil 138, 209-13
89.   Müller M, Bakos É, Welker E, Váradi A, Germann UA, Gottesman MM, Morse BS, Roninson IB and Sarkadi B (1996) [8567633]
  Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein.
  J Biol Chem 271, 1877-83
90.   Németh K, Fekete G, Kiss E, Váradi A, Holics K and Ujhelyi R (1996) [8803789]
  Analysis of five CFTR mutations in Hungarian cystic fibrosis patients.
  J Inherit Metab Dis 19, 378
91.   Bakos É, Hegedűs T, Holló Z, Welker E, Tusnády GE, Zaman GJ, Flens MJ, Váradi A and Sarkadi B (1996) [8647833]
  Membrane topology and glycosylation of the human multidrug resistance-associated protein.
  J Biol Chem 271, 12322-6
92.   Németh K, Holics K, Ujhelyi R, Váradi A and Fekete G (1996) [8649752]
  [Analysis of five mutations of cystic fibrosis occurring in the Hungarian population]
  Orv Hetil 137, 899-903
93.   Welker E, Szabó K, Holló Z, Müller M, Sarkadi B and Váradi A (1995) [7488154]
  Drug-stimulated ATPase activity of a deletion mutant of the human multidrug-resistance protein (MDR1).
  Biochem Bioph Res Co 216, 602-9
94.   Magyar A, Bakos É and Váradi A (1995) [7575407]
  Structure and tissue-specific expression of the Drosophila melanogaster organellar-type Ca(2+)-ATPase gene.
  Biochem J 310 (Pt 3), 757-63
95.   Fekete G, Váradi A, Pipiras E, Németh K, Réthy LA, Holics K and Ujhelyi R (1992) [1408077]
  [Detection of delta F508 mutation in cystic fibrosis]
  Orv Hetil 133, 2423-4, 2427-30
96.   Magyar A and Váradi A (1990) [2148477]
  Molecular cloning and chromosomal localization of a sarco/endoplasmic reticulum-type Ca2(+)-ATPase of Drosophila melanogaster.
  Biochem Bioph Res Co 173, 872-7
97.   Váradi A, Gilmore-Heber M and Benz EJ (1989) [2557235]
  Amplification of the phosphorylation site-ATP-binding site cDNA fragment of the Na+,K(+)-ATPase and the Ca2(+)-ATPase of Drosophila melanogaster by polymerase chain reaction.
  FEBS Lett 258, 203-7
98.   Váradi A and Scheraga HA (1986) [2937452]
  Localization of segments essential for polymerization and for calcium binding in the gamma-chain of human fibrinogen.
  Biochemistry-us 25, 519-28
99.   Váradi A and Patthy L (1984) [6722138]
  Beta(Leu121-Lys122) segment of fibrinogen is in a region essential for plasminogen binding by fibrin fragment E.
  Biochemistry-us 23, 2108-12
100.   Patthy L, Trexler M, Váli Z, Bányai L and Váradi A (1984) [6373375]
  Kringles: modules specialized for protein binding. Homology of the gelatin-binding region of fibronectin with the kringle structures of proteases.
  FEBS Lett 171, 131-6
101.   Horwitz BH, Váradi A and Scheraga HA (1984) [6592597]
  Localization of a fibrin gamma-chain polymerization site within segment Thr-374 to Glu-396 of human fibrinogen.
  P Natl Acad Sci Usa 81, 5980-4
102.   Bányai L, Váradi A and Patthy L (1983) [6685059]
  Common evolutionary origin of the fibrin-binding structures of fibronectin and tissue-type plasminogen activator.
  FEBS Lett 163, 37-41
103.   Váradi A and Patthy L (1983) [6222763]
  Location of plasminogen-binding sites in human fibrin(ogen).
  Biochemistry-us 22, 2440-6
104.   Váradi A and Patthy L (1981) [6797430]
  Kringle 5 of human plasminogen carries a benzamidine-binding site.
  Biochem Bioph Res Co 103, 97-102
105.   Varadi A and Pongor S (1979) [-100002732]
  Determination of sulfur-containing amino-acids by quantitative\n ion-exchange thin-layer chromatography
  J Chromatogr A 173, 419-424
106.   Patthy L, Varadi A, Thesz J and Kovacs K (1979) [499203]
  Identification of the C-1-phosphate-binding Arginine Residue of Rabbit-muscle Aldolase - Isolation of 1,2-cyclohexanedione-labeled Peptide by Chemisorption Chromatography
  Eur J Biochem 99, 309-13
107.   Cseke E, Váradi A, Szabolcsi G and Biszku E (1978) [729779]
  On the molecular sieving property of the human erythrocyte membrane and the localization of some glycolytic enzymes in the cell.
  FEBS Lett 96, 15-8
108.   Váradi A, Pongor S and Kaul AK (1976) [1007888]
  Quantitative determination of methionine in proteins: gas chromatography of methylthiocyanate liberated by cleavage with cyanogen bromide.
  Acta Biochim Biophys Acad Sci Hung 11, 87-93
109.   Holderith J, Toth T and Varadi A (1975) [-100002733]
  Minimizing time for gas-chromatographic analysis - finding optimum\n measuring parameters by means of a simplex method
  Magyar Kémiai folyóirat 81, 162-164
110.   Váradi A (1975) [1133142]
  Thin-layer chromatography on a chromatosheet coated with resin in different ionic forms for the separation of amino acid mixtures containing asparagine and glutamine.
  J Chromatogr A 110, 166-70

Books or book chapters

1.   Homolya L, Varadi A and Sarkadi B (2002)
  Multidrug Resistance-Associated Proteins: Export Pumps for Conjugates with Glutathione,Glucuronate or Sulfate.
  Thiol Metabolism and Redox Regulation of Cellular Functions , 107
2.   Váradi A, Tusnády GE and Sarkadi B (2002)
  Membrane topology of human ABC proteins.
  The book of ABC proteins , 37-47
3.   Varadi A, Szakács G, Bakos E and Sarkadi B (2002)
  P glycoprotein and the Mechanism of Multidrug Resistance
  Mechanisms of Drug Resistance in Epilepsy ISBN: 047084146X,
4.   Váradi A, Tusnády GE, Bakos É and Sarkadi B (1998)
  Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs.
  Multiple drug resistance in cancer: molecular, cellular and clinical aspects. , 71-80
5.   Varadi A (1997)
  Színlátás.
  Molekuláris medicina , 244-247
6.   Varadi A (1997)
  Hemofilia A és B.
  Molekuláris medicina , 221-227
7.   Varadi A (1997)
  A génhibák felderitésének módszerei.
  Molekuláris medicina , 86-89
8.   Varadi A and Papp Z (1995)
  Klinikai molekularis genetika.
  , 103-121
9.   Patthy L, Trexler M, Váli Z, Bányai L and Váradi A (1984)
  Kringle structures of human plasminogen: their role in the regulation of fibrinolysis.
  Symp.Biol.Hung. 25, 73-79